| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Srvp/ Cfo/ Prin Fin &Acct Ofcr | Srvp/ Cfo/ Prin. Fin&Acctg. Off | SVP &CFO
2 companies
Hamill John P. serves as a SVP &CFO at WINT and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 9 buys and 0 sells. Those positions are worth an estimated $27K at current prices.
Historically, Hamill John P.'s trades have earned a below-average insider score of 29/100 across 4 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -48.9%.
The biggest single holding is WINT (~$27K) as SVP &CFO. Net of sales, the recent Form 4 record there shows accumulation of 6,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | APRE Aprea Therapeutics, Inc. | Srvp/ Cfo/ Prin Fin &Acct Ofcr | Buy | 5,700 | $0.89 | $5,073.00 | +20.6% | - | - | |
| Dec 10, 2025 | APRE Aprea Therapeutics, Inc. | Srvp/ Cfo/ Prin Fin &Acct Ofcr | Buy | 5,000 | $1.17 | $5,825.00 | +22.0% | -8.9% | - | |
| Oct 11, 2024 | APRE Aprea Therapeutics, Inc. | Srvp/ Cfo/ Prin Fin &Acct Ofcr | Buy | 50 | $2.46 | $123.19 | +0.3% | +40.6% | -45.4% | |
| Oct 10, 2024 | APRE Aprea Therapeutics, Inc. | Srvp/ Cfo/ Prin Fin &Acct Ofcr | Buy | 450 | $2.61 | $1,174.50 | +2.4% | +55.1% | -44.1% | |
| Mar 13, 2024 | APRE Aprea Therapeutics, Inc. | Srvp/ Cfo/ Prin Fin &Acct Ofcr | Buy | 1,010 | $7.29 | $7,362.90 | +7.0% | -19.6% | -57.2% | |
| Jul 26, 2022 | WINT Windtree Therapeutics Inc /de/ | SVP &CFO | Buy | 3,000 | $0.37 | $1,099.80 | +4.3% | - | - | |
| Apr 16, 2021 | WINT Windtree Therapeutics Inc /de/ | SVP &CFO | Buy | 1,000 | $2.07 | $2,066.90 | +40.0% | - | - | |
| Mar 25, 2021 | WINT Windtree Therapeutics Inc /de/ | SVP &CFO | Buy | 1,500 | $3.25 | $4,875.00 | +150.0% | - | - | |
| Oct 7, 2020 | WINT Windtree Therapeutics Inc /de/ | SVP &CFO | Buy | 1,000 | $5.27 | $5,270.00 | New | - | - |